Display Settings:

Format

Send to:

Choose Destination
    Acta Pharmacol Sin. 2000 Nov;21(11):1021-6.

    High-throughput screening for human collagenase 1 inhibitors.

    Source

    National Centers for Drug Screening, Shanghai Institute of Materia Medica, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai 200031, China.

    Abstract

    AIM:

    To establish a high-throughput method for inhibitor screening using a recombinant collagenase catalytic domain.

    METHODS:

    Human collagenase 1 catalytic domain protein was expressed in E coli and used for screening a set of 2720 compounds in a high-throughput fashion.

    RESULTS:

    The screening was accomplished within 2 h and 10 min with consumption of each compound at 4 micrograms. Sixty-six compounds were identified with > 60% inhibitory activity at 20 mg/L, among which 44 compounds were confirmed by subsequent testing at multiple concentrations. The most potent compound showed an IC50 at 4.3 mumol/L, and there were total 15 compounds with IC50 less than 20 mumol/L.

    CONCLUSION:

    The high-throughput method using the recombinant collagenase is fast, effective and practical in identifying inhibitors.

    PMID:
    11501057
    [PubMed - indexed for MEDLINE]
    Free full text

      Supplemental Content

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk